Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Submitted by
admin
on December 11, 2017 - 11:18pm
Source:
Xconomy
News Tags:
Eli Lilly
stomach cancer
Cyramza
Headline:
Lilly Nixes Expansion of Stomach Cancer Drug After Mixed Study Results
Do Not Allow Advertisers to Use My Personal information
